A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples